Literature DB >> 10163576

ACE inhibition in diabetic patients. Economic implications.

R A Rodby1, E J Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10163576     DOI: 10.2165/00019053-199610040-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

1.  Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus.

Authors:  J E Siegel; A S Krolewski; J H Warram; M C Weinstein
Journal:  J Am Soc Nephrol       Date:  1992-10       Impact factor: 10.121

2.  An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.

Authors:  R A Rodby; L M Firth; E J Lewis
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

3.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

Authors:  G Viberti; C E Mogensen; L C Groop; J F Pauls
Journal:  JAMA       Date:  1994-01-26       Impact factor: 56.272

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

Authors:  K Borch-Johnsen; H Wenzel; G C Viberti; C E Mogensen
Journal:  BMJ       Date:  1993-06-26

6.  Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus.

Authors:  K Zeller; E Whittaker; L Sullivan; P Raskin; H R Jacobson
Journal:  N Engl J Med       Date:  1991-01-10       Impact factor: 91.245

7.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

8.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

Authors:  E R Mathiesen; E Hommel; J Giese; H H Parving
Journal:  BMJ       Date:  1991-07-13

9.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

10.  Short and long term effects of antihypertensive therapy in the diabetic rat.

Authors:  S Anderson; H G Rennke; D L Garcia; B M Brenner
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

  10 in total
  1 in total

1.  Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.

Authors:  L Garattini; M Brunetti; F Salvioni; M Barosi
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.